← Back to Clinical Trials
Recruiting NCT06946082

NCT06946082 The Effect of Upper Extremity Motor Function, Trunk Control and Motor Imagery Ability on Turkish Language Skills in Individuals With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06946082
Status Recruiting
Phase —
Sponsor Izmir Bakircay University
Condition Hemiplegia
Study Type OBSERVATIONAL
Enrollment 101 participants
Start Date 2024-12-10
Primary Completion 2025-09-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 101 participants in total. It began in 2024-12-10 with a primary completion date of 2025-09-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A large number of people have a stroke each year and it is a major cause of disability worldwide. Upper limb motor impairments, aphasia, body control problems and decreased motor imagery ability are common after stroke. Although there are studies showing that these impairments may be related to each other, there is no comprehensive study examining the relationship between Turkish language skills and these motor functions. The aim of this study was to evaluate the relationship between Turkish language skills and upper extremity motor function, trunk control and motor imagery ability in stroke patients.

Eligibility Criteria

Inclusion Criteria: * 18 years of age or older * Stroke onset more than 1 week * Not having practiced imagery before * Being a native speaker of Turkish * Standardized Mini Mental Test (SMMT) Score of 24 and above * History of cerebrovascular events * Not having any neurological disorder other than stroke * The ability to grasp and hold a 2.5 cm cube Exclusion Criteria: * No consent from the family or person * Having had a stroke before * Severe hearing or vision loss * Individuals are excluded if they have other primary medical conditions that may affect language and motor functions (e.g. brain tumor, Parkinson's disease, severe post-stroke depression, Alzheimer's disease) or have undergone surgery.

Contact & Investigator

Central Contact

Emine Timur, Bachelor

✉ 6031010@bakircay.edu.tr

📞 +90 542 592 96 41

Frequently Asked Questions

Who can join the NCT06946082 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hemiplegia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06946082 currently recruiting?

Yes, NCT06946082 is actively recruiting participants. Contact the research team at 6031010@bakircay.edu.tr for enrollment information.

Where is the NCT06946082 trial being conducted?

This trial is being conducted at Izmir, Turkey (Türkiye).

Who is sponsoring the NCT06946082 clinical trial?

NCT06946082 is sponsored by Izmir Bakircay University. The trial plans to enroll 101 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology